YungShin Global Holding Corporation (TPE:3705)

Market Cap	14.94B -15.9%
Revenue (ttm)	8.04B -4.5%
Net Income	791.68M -35.5%
EPS	2.97 -35.6%
Shares Out	266.36M
PE Ratio	18.88
Forward PE	n/a
Dividend	3.00 (5.39%)
Ex-Dividend Date	Jun 24, 2026

Volume	155,387
Average Volume	187,942
Open	55.70
Previous Close	55.70
Day's Range	55.70 - 56.30
52-Week Range	51.90 - 65.60
Beta	0.08
RSI	59.76
Earnings Date	Aug 10, 2026

About YungShin Global Holding

YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, and Japan. YungShin Global Holding Corporation was founded in 1952 and is based in Taipei, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1952
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3705

Financial Performance

In 2025, YungShin Global Holding's revenue was 8.38 billion, an increase of 4.28% compared to the previous year's 8.03 billion. Earnings were 880.82 million, a decrease of -24.62%.